Key result
Capsid gene sequencing of Norovirus GII.4 variant Den Haag 2006b strains identified four distinct outbreaks in different departments and a fifth outbreak with possible inter-department spread.
Observational (n=60)
No
Capsid gene sequencing of Norovirus provides higher discrimination than polymerase sequencing, enabling detailed identification of nosocomial transmission routes and in vivo viral evolution.
May support capsid sequencing to map hospital NoV transmission; hypothesis-generating and requires prospective validation before practice change.
Norovirus (NoV) is a leading cause of gastroenteritis and genotype II.4 (GII.4) is responsible for the majority of nosocomial NoV infections. Our objective was to examine whether sequencing of the capsid gene might be a useful tool for the hospital outbreak investigation to define possible transmission routes. All NoV positive samples submitted from one university hospital during the 2007/8 season were selected. Genotyping of selected samples by partial polymerase gene sequencing had shown that the majority belonged to the GII.4 variant Den Haag 2006b and had identical polymerase sequences. Sequences of the capsid gene (1412 nucleotides) were obtained from the first available sample from 55 patients. From six immunocompromised patients with persistent infections a second sample was also included. As a control for a point-source outbreak, five samples from a foodborne outbreak caused by the same GII.4 variant were analyzed. Forty-seven of the inpatients (85%) were infected with the GII.4 variant Den Haag 2006b. Phylogenetic analysis of the Den Haag 2006b sequences identified four distinct outbreaks in different departments and a fifth outbreak with possible inter-department spread. In addition, a more heterogeneous cluster with evidence of repeated introductions from the community, but also possible inter-department spread was observed. In all six patients with paired sequences, evidence for in vivo evolution of the virus was found. Capsid gene sequencing showed substantial sequence variation among NoV GII.4 variant Den Haag 2006b strains from one single institution during a nine months' period. This method proved useful to understand the local epidemiology and, when used promptly, has the potential to make infection control measures more targeted.
No takes yet. Share an insight, caveat, or question.
Holzknecht et al. (2015) conducted an observational in Norovirus infection (n=60). Capsid gene sequencing vs. Polymerase gene sequencing was evaluated on Identification of transmission routes and sequence variation. Capsid gene sequencing of Norovirus GII.4 variant Den Haag 2006b strains identified four distinct outbreaks in different departments and a fifth outbreak with possible inter-department spread.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: